The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.00 (0.00%)
Spread: 0.04 (1.053%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.80
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Commercial Distribution Agreements

14 Dec 2016 07:00

RNS Number : 7736R
Plant Health Care PLC
14 December 2016
 

PLANT HEALTH CARE PLC

 

("Plant Health Care", "PHC" or the "Company")

 

New Commercial Distribution Agreements

Plant Health Care® (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce four new commercial distribution arrangements, which together represent important progress in driving sales growth in 2017 and beyond.

 

- Plant Health Care has reached agreement with Talc U.S.A. to launch Inceptive™, a novel product containing PHC's patented Harpin 𝜶β technology, which will be mixed with a Talc U.S.A. seed lubricant for corn seed treatment in the USA. Inceptive has been shown in replicated trials to bring substantial benefits on corn such as improved vigour, heightened defense responses and increased yield. This agreement will provide PHC with additional access to the 90 million acre corn market in the USA.

 

- Plant Health Care conducted a product demonstration programme, in conjunction with the Florida Fruit & Vegetable Association, to promote the use of PHC's Employ® product (containing PHC's patented Harpin 𝜶β technology), aimed at reducing the impact of fruit drop in the presence of citrus greening, caused by the Huang Long Bing (HLB) bacterium. This disease has caused devastating damage in citrus in Florida over the last four years, with up to 80% of trees across the state reported as affected. Use of Employ has been shown in replicated trials to reduce losses by more than 10% in the presence of citrus trees infected by HLB. Based on these encouraging results, PHC will be distributing Employ in Florida directly with regional distributors.

 

- Plant Health Care has reached agreement with EDAF Unipessoal LDA, to distribute Plant Health Care's proprietary ProAct® and Myconate® products in Portugal.

 

- Plant Health Care continues to build on its recent success in South Africa with its Harpin 𝜶β and Myconate products and is now preparing to expand distribution to 23 countries in sub-Saharan Africa through its distribution agreement with DuxAgri (Pty) Ltd. Plant Health Care is creating significant momentum in the region by concentrating sales to higher value crops, such as sugar cane, vegetables, citrus, pears and macadamia nuts which all receive multiple product applications per year.

 

Dr Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, commented: "Over the last three years, we have steadily built compelling evidence of the efficacy of products based on the Company's patented Harpin technology. The distribution arrangements announced today reflect further progress in developing sales of the product in significant markets. We expect that these agreements, together with other projects in progress, will drive strong sales growth of products based on Harpin over the coming years."

 

Enquiries:

 

Plant Health Care plcDr Chris Richards, Executive Chairman and Interim CEOTel: +44 1837 880083

 

Liberum Capital - Nomad and BrokerClayton Bush / Chris ClarkeTel: +44 (0) 20 3100 2000

Company website: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLXLLFQLFFFBE
Date   Source Headline
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding
9th May 20131:20 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.